Insomnia Market Trends, Share & Demand by 2034

Coverage: By Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00005214
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 09, 2026
Insomnia Market Trends, Share & Demand by 2034
Report Date: April 09, 2026   |   Report Code: TIPRE00005214 Email: sales@theinsightpartners.com

2025 Market Size

US$ 4.53 Bn

Base year value

2034 Forecast

US$ 5.88 Bn

Projected by 2034

CAGR 2026-2034

2.94 %

Growth rate

Addressable Market

US$ 47.26 Bn

(2026-2034)

Insomnia market size is expected to reach US$ 5.88 Billion by 2034 from US$ 4.53 Billion in 2025. The market is anticipated to register a CAGR of 2.94% during the forecast period 2026–2034.

The report is segmented based on Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies). The global analysis is further broken down at the regional level and major countries. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Insomnia Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Insomnia Market Segmentation Drug Class

  1. Antidepressants
  2. Melatonin Antagonist
  3. Benzodiazepines
  4. Nonbenzodiazepines
  5. Orexin Antagonist

Distribution Channel

  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Drug Stores
  4. Online Pharmacies

Market Assessment and Insights

  • Global market for Insomnia was valued at US$ 4.53 Billion in 2025
  • Annual market size is expected to reach US$ 5.88 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 47.26 Billion
  • Market is anticipated to register a CAGR of 2.94% during the forecast period
  • The United States represents a key market, supported by Rising Prevalence of Sleep Disorders, Growing Geriatric Population, Increased Stress Levels, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Development of Novel Therapeutics, Expansion of Telehealth Services, Integration of Sleep Technology are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Mallinckrodt, Eisai Co., Ltd., Merck Sharp & Dohme Corp. (Merck & Co., Inc), Galt Pharmaceuticals, LLC., Pfizer Inc., Sanofi, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Insomnia Market: Strategic Insights

insomnia-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Insomnia Market Growth Drivers

  1. Rising Prevalence of Sleep Disorders: Increase in prevalence of insomnia and other sleep disorders globally.
  2. Growing Geriatric Population: Aging population is more susceptible to sleep disturbances.
  3. Increased Stress Levels: Modern lifestyle with its associated stressors contributes to insomnia.

Insomnia Market Future Trends

  1. Focus on Non-Pharmacological Treatments: Growing interest in non-drug therapies like cognitive behavioral therapy (CBT) for insomnia (CBT-I).
  2. Personalized Medicine: Tailoring treatment plans based on individual sleep patterns and underlying causes.
  3. Digital Therapeutics: Use of mobile apps and wearable devices for sleep tracking, relaxation techniques, and personalized feedback.

Insomnia Market Opportunities

  1. Development of Novel Therapeutics: Research and development of new medications with improved efficacy and fewer side effects.
  2. Expansion of Telehealth Services: Providing access to sleep specialists and therapists through remote consultations.
  3. Integration of Sleep Technology: Developing innovative sleep-tracking devices and smart home technologies to improve sleep quality.

Insomnia Market Report Scope

Report Attribute Details
Market size in 2025 US$ 4.53 Billion
Market Size by 2034 US$ 5.88 Billion
Global CAGR (2026 - 2034) 2.94%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Drug Class
  • Antidepressants
  • Melatonin Antagonist
  • Benzodiazepines
  • Nonbenzodiazepines
  • Orexin Antagonist
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Mallinckrodt
  • Eisai Co., Ltd.
  • Merck Sharp & Dohme Corp. (Merck & Co., Inc)
  • Galt Pharmaceuticals, LLC.
  • Pfizer Inc.
  • Sanofi
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Vanda Pharmaceuticals

Insomnia Market Players Density: Understanding Its Impact on Business Dynamics

The Insomnia Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

insomnia-market-cagr

Key Selling Points
  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Insomnia Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Insomnia Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

The leading players are: Mallinckrodt, Eisai Co., Ltd., Merck Sharp & Dohme Corp. (Merck & Co., Inc), Galt Pharmaceuticals, LLC., Pfizer Inc., Sanofi, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals

The future trends of the Insomnia Market are: Focus on Non-Pharmacological Treatments, Personalized Medicine and Digital Therapeutics

Insomnia Market is expected to grow at a CAGR of 2.94% from 2026 to 2034

The driving factors impacting the Insomnia Market are: Rising Prevalence of Sleep Disorders, Growing Geriatric Population and Increased Stress Levels
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA